
The US Senate Judiciary Committee approved on Thursday, September 23, legislation that would allow state attorneys general to choose which court hears their antitrust cases, a bill that could affect a pending lawsuit against Google.
The bill was sent to the full Senate by a voice vote, reported Reuters.
Senator Amy Klobuchar, a Democrat who sponsored the measure with Republican Mike Lee, said the measure would prevent state lawsuits from getting caught up in lengthy, multi-district litigation that takes years to resolve.
“This bill would simply strengthen the enforcement of our antitrust laws,” she said.
Senator Alex Padilla, a California Democrat, and others expressed concern about the bill being retroactive, saying that it would affect a case that the Texas attorney general and others filed against Google.
In August, a judicial panel ruled against the attorneys general to move that fight from Texas to the Southern District of New York, where other similar cases were being heard.
The text of the bill says that it would go into effect on June 1, 2021, before the panel ruled.
Texas joined with other states to sue Google in mid-December, accusing the search and advertising company of breaking antitrust law by dominating all steps in the process of placing digital advertising. Publishers complain that one result has been lower revenues. Google has denied wrongdoing.
A companion measure to the Senate bill was one of six that passed the US House Judiciary Committee in June, four of which were aimed specifically at reining in the power of big tech. It has not yet been considered by the full House, however.
Congress is also considering sharp increases in the budgets of the Justice Department’s Antitrust Division and Federal Trade Commission, both of which enforce antitrust law.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas